FDA clears Roche's automated type-specific herpes tests

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assays for use on cobas® modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection. 

"These are the first automated type-specific herpes tests available for integrated analyzer platforms, which will enable labs to integrate efficient herpes testing into their existing workflow," said Randy Pritchard, vice president of marketing at Roche Diagnostics Corporation. "The approval of the type-specific assays also means healthcare providers now have another tool to give them greater confidence in their diagnosis and overall patient care."

The addition of these tests further expands the company's infectious disease test portfolio for labs of all sizes. Roche currently offers the broadest test menu available on an integrated (chemistry and immunoassay) platform.

Source:

Roche Diagnostics

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Diagnostics Limited. (2019, June 20). FDA clears Roche's automated type-specific herpes tests. News-Medical. Retrieved on August 25, 2019 from https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx.

  • MLA

    Roche Diagnostics Limited. "FDA clears Roche's automated type-specific herpes tests". News-Medical. 25 August 2019. <https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx>.

  • Chicago

    Roche Diagnostics Limited. "FDA clears Roche's automated type-specific herpes tests". News-Medical. https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx. (accessed August 25, 2019).

  • Harvard

    Roche Diagnostics Limited. 2019. FDA clears Roche's automated type-specific herpes tests. News-Medical, viewed 25 August 2019, https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche